Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | US

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Ipsen Developing innovative medicines for Oncology, Rare Diseases, and Neuroscience.	France	IPN
IRLAB Therapeutics Developing novel drugs for Parkinson's disease and other neurodegenerative CNS disorders.	Sweden	IRLAB
IRONWOOD PHARMACEUTICALS INC Develops and commercializes therapies for GI diseases like IBS-C and chronic constipation.	United States of America	IRWD
ISU Abxis Co., Ltd. Developing antibody-based immunotherapies for oncology and rare diseases.	South Korea	086890
Iterum Therapeutics plc Develops novel oral & IV anti-infectives to combat multi-drug resistant pathogens.	United States of America	ITRM
IVF HARTMANN Holding AG Produces and distributes medical supplies, wound care, and hygiene items for global healthcare.	Switzerland	VBSN
Jade Biosciences, Inc. Clinical-stage biotech developing therapies for autoimmune and inflammatory diseases.	United States of America	JBIO
Jaguar Health, Inc. Develops plant-based, non-opioid GI therapies for humans and animals.	United States of America	JAGX
Janux Therapeutics, Inc. Developing tumor-activated immunotherapies to treat cancer while minimizing systemic toxicities.	United States of America	JANX
Japan Tissue Engineering Co., Ltd. Pioneers regenerative medicine with tissue products, CDMO services, and research models.	Japan	7774